Chief.AI secures £370k grant funding from Innovate UK to build an AI platform for drug discovery.
The grant will fund an online platform providing researchers with access to AI models and algorithms.
£370KGrant
Chief.AI builds an online platform that provides researchers with access to downloadable AI models and algorithms for drug discovery.
Chief.AI has secured £370k in grant funding from Innovate UK alongside a partnership with Medicines Discovery Catapult. The capital will be used to build a searchable online platform providing UK researchers with off-the-shelf AI models and high-quality data. The initiative aims to make advanced artificial intelligence more accessible to small and medium enterprises in the drug discovery sector.
From the founder
"The UK is where the first industrial revolution began, and we now want to accelerate AI provision throughout the world to become one of the biggest industrial force multipliers of the twenty first century. Chief.AI will make the discovery of drugs more efficient, at lower cost and will diagnose diseases earlier to enable better outcomes."
WA
Waqar Ali
Founder at Chief.AI
Investor perspective
"This partnership and funding clearly indicate the importance and value of artificial intelligence as a new approach to support UK SMEs and reinvigorate drug discovery. Our aim is to help deliver a platform which is of high value to UK SMEs to advance their own drug discovery projects faster and more efficiently by accessing otherwise inaccessible, complex technical expertise"
JO
John Overington
Chief Informatics Officer, Medicines Discovery Catapult
Use of funds
- 01Continue product development
